Benzinga | May 13, 2021 04:45PM EDT

KemPharm Q1 EPS $(0.54) Misses $(0.17) Estimate, Sales $12.10M Beat $2.10M Estimate

KemPharm (NASDAQ:KMPH) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.17) by 217.65 percent. This is a 350 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $12.10 million which beat the analyst consensus estimate of $2.10 million by 476.19 percent. This is a 479.22 percent increase over sales of $2.09 million the same period last year.